tested CAIX-specific CAR T cells against a glioblastoma model, establishing carbonic anhydrase IX (CAIX) as a targeting hypoxia downstream signaling protein characteristically expressed in glioblastoma and found robust efficacy (128). This evidence concerns the gene CA9 and glioblastoma.